相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lack of intrafollicular memory CD4+T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
Patrizia Mondello et al.
BLOOD CANCER JOURNAL (2021)
Epidemiology of Follicular Lymphoma
James R. Cerhan
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2020)
Mass Cytometry Analysis Reveals that Specific Intratumoral CD4+ T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma
Zhi-Zhang Yang et al.
CELL REPORTS (2019)
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Joshua W. D. Tobin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Chromatin modifying gene mutations in follicular lymphoma
Michael R. Green
BLOOD (2018)
Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3+ Tregs in follicular lymphoma
Lilli S. Nelson et al.
BRITISH JOURNAL OF CANCER (2015)
FOXP3+ regulatory T cells and their functional regulation
Zhiyuan Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Inhibitory receptors as targets for cancer immunotherapy
Meghan E. Turnis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Disruption of Follicular Dendritic Cells-Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib)
Alba Matas-Cespedes et al.
CLINICAL CANCER RESEARCH (2014)
Pattern of CD14+ Follicular Dendritic Cells and PD1+ T Cells Independently Predicts Time to Transformation in Follicular Lymphoma
Jacob P. Smeltzer et al.
CLINICAL CANCER RESEARCH (2014)
Nomenclature of monocytes and dendritic cells in blood
Loems Ziegler-Heitbrock et al.
BLOOD (2010)
Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols
Daphne de Jong et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling
Richard J. Byers et al.
BLOOD (2008)
A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone
Minna Taskinen et al.
CLINICAL CANCER RESEARCH (2007)
The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma
Ad Koster et al.
HAEMATOLOGICA (2007)
Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma
Annuska M. Glas et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients
Tomas Alvaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial
Marinus H. J. van Oers et al.
BLOOD (2006)
Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome
Abigail M. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Joaquim Carreras et al.
BLOOD (2006)
Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP
Antti Harjunpaa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome
Christian Buske et al.
BLOOD (2006)
Low histologic grade follicular lymphoma with high proliferation index - Morphologic and clinical features
SA Wang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Analysis of multiple biomarkers, shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
P Farinha et al.
BLOOD (2005)
Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment
AM Glas et al.
BLOOD (2005)
Follicular lymphoma international prognostic index
P Solal-Céligny et al.
BLOOD (2004)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)
分享论文
